Curium Further Expands European Availability of PYLCLARI – an Innovative 18F-PSMA PET Radiopharmaceutical Indicated in Patients with Prostate Cancer
Curium, a world leader in nuclear medicine, today announced that in Estonia, Finland, Latvia, and Sweden, PYLCLARI® is now ...
BioSpace5d
Curium Expands European Supply of Iodine-131 Diagnostic Capsules with New Partnership Agreement with Izotop
PARIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has expanded its existing partnership with Institute of Isotopes Co. Ltd. (Izotop) to make ...
The News Portsmouth7d
Lakeside North Harbour welcomes Curium to expanded office premises with new lettings agreement
Lakeside North Harbour (Lakeside), Portsmouth’s leading workspace, has announced a new lettings agreement with Curium - the world-leading nuclear medicine company. Did you know with a Digital ...
Finanznachrichten5d
Curium Expands European Supply of Iodine-131 Diagnostic Capsules with New Partnership Agreement with Izotop
PARIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has expanded its existing partnership with Institute of Isotopes Co. Ltd. (Izotop ...
Finanznachrichten7d
Curium Further Expands European Availability of PYLCLARI - an Innovative 18F-PSMA PET Radiopharmaceutical Indicated in Patients with Prostate Cancer
PARIS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine ... prostate cancer is one of the most common cancers among men with around 25,000 new cases diagnosed ...